Form 4: Phathom Pharmaceuticals CFO Molly Henderson Reports Stock Sale to Cover Tax Obligations

Molly Henderson, CFO and CBO of Phathom Pharmaceuticals, sold 3,678 shares of common stock on April 7, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On April 7, 2025, Molly Henderson, the CFO and CBO of Phathom Pharmaceuticals, sold 3,678 shares of the company's common stock.
• The sale was executed at a weighted average price of $4.5513 per share.
• The shares were sold in two transactions with prices ranging from $4.55 to $4.57.
• The purpose of the sale was to satisfy tax withholding obligations upon the settlement of restricted stock units.
• Following the transaction, Henderson directly owns 89,868 shares of Phathom Pharmaceuticals common stock.
• Henderson also indirectly owns 1,911.27 shares through a 401(k) plan.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine transaction to cover tax obligations.

Industry Context

This is a routine Form 4 filing, reflecting a corporate insider's stock sale to cover tax obligations, a common practice.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares, but the effect is likely minimal given the relatively small volume of shares sold.

Key Dates

Keywords

Phathom Pharmaceuticals, Molly Henderson, stock sale, Form 4, CFO, tax obligations, restricted stock units, PHAT